Moreover, upregulation of SPOCK1 was significantly associated with advanced clinical stages, larger tumor sizes, lymph node and distal metastases, and shorter OS, DSS, and DFS times of ccRCC patients. The gene discussed is SPOCK1; the disease is neoplasm.